Huntington National Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.4K | Buy |
699
+209
| +43% | +$7.6K | ﹤0.01% | 1486 |
|
|
2025
Q1 | $17.7K | Sell |
490
-65
| -12% | -$2.35K | ﹤0.01% | 1566 |
|
|
2024
Q4 | $23.3K | Buy |
555
+7
| +1% | +$294 | ﹤0.01% | 1496 |
|
|
2024
Q3 | $30.4K | Buy |
548
+71
| +15% | +$3.94K | ﹤0.01% | 1376 |
|
|
2024
Q2 | $19.6K | Buy |
477
+46
| +11% | +$1.89K | ﹤0.01% | 1461 |
|
|
2024
Q1 | $20.1K | Sell |
431
-11
| -2% | -$514 | ﹤0.01% | 1456 |
|
|
2023
Q4 | $21.1K | Sell |
442
-75
| -15% | -$3.59K | ﹤0.01% | 1401 |
|
|
2023
Q3 | $18.4K | Buy |
517
+153
| +42% | +$5.45K | ﹤0.01% | 1374 |
|
|
2023
Q2 | $16.8K | Buy |
+364
| New | +$16.8K | ﹤0.01% | 1417 |
|
|
2019
Q1 | – | Sell |
-60
| Closed | -$3K | – | 1841 |
|
|
2018
Q4 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 1527 |
|
|
2016
Q4 | – | Sell |
-9
| Closed | – | – | 1501 |
|
|
2016
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 1566 |
|
|
2016
Q2 | $0 | Sell |
9
-302
| -97% | – | ﹤0.01% | 1673 |
|
|
2016
Q1 | $19K | Buy |
311
+111
| +56% | +$6.78K | ﹤0.01% | 1369 |
|
|
2015
Q4 | $22K | Sell |
200
-34
| -15% | -$3.74K | ﹤0.01% | 1202 |
|
|
2015
Q3 | $23K | Sell |
234
-142
| -38% | -$14K | ﹤0.01% | 1225 |
|
|
2015
Q2 | $38K | Buy |
376
+65
| +21% | +$6.57K | ﹤0.01% | 1184 |
|
|
2015
Q1 | $19K | Buy |
+311
| New | +$19K | ﹤0.01% | 1374 |
|